Title: Mamand S, et al. Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma. Sci Rep. 2018 Sep 21;8(1):14216.
1346599-76-5 | Hydroxy Adapalene | AA009EJ6 | MFCD28964029
1246819-35-1 | 3-Hydroxy Benzopyrene-d11 | AA009ERL
139493-40-6 | 3,11-DiMethylchrysene | AA009EZI | MFCD29919961
1246355-58-7 | Bodipy C12-CeraMide | AA009F59 | MFCD22416770
1306746-93-9 | 2-Bromo-3-(4-thiomorpholino)prop-1-ene | AA009FDG | MFCD18915041
1414851-57-2 | N-(9-Deoxy-epi-cinchonidin-9-yl)picolinamide | AA009FLP | MFCD27976819
1246816-17-0 | 8-Chloro-5-isoquinolinesulfonic Acid | AA009FT1 | MFCD29050085
130868-43-8 | 2-(Iodomethyl)oxepane | AA009GFT | MFCD06410709
1217803-39-8 | (2S,4S)-1-Boc-2-hydroxymethyl-4-amino pyrrolidine-hcl | AA009GP6 | MFCD10568358
1247169-18-1 | 5-aMino-1-(4-fluorophenyl)-1H-pyrazol-3-ol | AA009HLB | MFCD14607820